Identifying Patients With Inflammatory Bowel Diseases in an Administrative Health Claims Database: Do Algorithms

Yizhou Ye1, Sudhakar Manne1, Dimitri Bennett1,2

  • 1Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.

Insights

Different algorithms identify varying numbers of inflammatory bowel disease patients in health claims data. This highlights the critical need for algorithm validation to ensure accurate patient identification and disease classification.

Area of Science:

  • Health Informatics
  • Gastroenterology
  • Epidemiology

Background:

  • Administrative health claims databases are utilized for patient and disease outcome detection.
  • Accurate identification of inflammatory bowel disease (IBD) patients is crucial for research and clinical management.

Purpose of the Study:

  • To compare the performance of different algorithms in identifying patients with inflammatory bowel disease (IBD) classifications using a single administrative claims database.
  • To assess the variability in patient cohort sizes and disease proportions based on algorithm selection.

Main Methods:

  • A literature review identified algorithms for defining IBD, ulcerative colitis, Crohn's disease, and IBD unspecified in claims databases.
  • Three selected algorithms (A, B, and C) were applied to the Optum Clinformatics® Data Mart database (June 2000–March 2017).
  • Patient cohorts identified by each algorithm were compared for size and disease classification distribution.

Main Results:

  • Algorithms identified significantly different numbers of total IBD patients (323,833; 246,953; 171,537).
  • Proportions varied: ulcerative colitis (32.0%–47.5%), Crohn's disease (38.6%–43.8%), and IBD unspecified (8.7%–26.6%).
  • Only 5.1% of IBD unspecified patients were identified by all three algorithms; Algorithm C identified the smallest cohorts for most categories.

Conclusions:

  • This study is the first to compare IBD patient identification across multiple algorithms within a single claims database.
  • Significant discrepancies in patient identification and classification underscore the need for algorithm validation.
  • Validated algorithms are essential for accurate epidemiological studies and resource allocation in IBD research.

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
585
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
884
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
814
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
706
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
414
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
411